Medication interactions: Anyone on prescription medications should discuss potential interactions with healthcare providers before starting peptide protocols
Safety in patients with existing mild-moderate liver disease Correlation between weight loss and estimated liver fat reduction TRIUMPH-2 (Ongoing, Expected 2026) Primary Endpoints: Weight loss in diabetic patients HbA1c reduction Secondary Endpoints (Liver): Liver enzymes Metabolic markers Diabetic Population Note: Higher prevalence of MASLD/NASH (~40-50%), so liver benefits particularly important in this group
FAM and its predecessors were featured in two National Academies of Science reports, 20,21 and variants have been developed globally
Frequently asked questions What is GHK-Cu used for in research
It's crucial for fat metabolism and cellular signaling
Our team will assess your individual health needs, discuss your weight loss goals, and determine if Zepbound is an appropriate treatment option for you